Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
237 CHF | -0.02% | +5.39% | -3.19% |
09:09am | Roche: Breakthrough designation for inavolisib in breast cancer | CF |
07:39am | Roche's Inavolisib Breast Cancer Treatment Gets FDA Breakthrough Therapy Designation | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.19% | 210B | |
+34.35% | 705B | |
+30.88% | 583B | |
-3.49% | 364B | |
+20.15% | 332B | |
+6.19% | 291B | |
+14.95% | 238B | |
+10.42% | 209B | |
+9.21% | 169B | |
-0.90% | 162B |
- Stock Market
- Equities
- ROG Stock
- News Roche Holding AG
- Roche’s Multiple Sclerosis Injection Controls Relapses, Brain Lesions in Late-stage Trial